New approaches to increase statistical power in TBI trials: Insights from the IMPACT study

Acta Neurochirurgica, Supplementum

Volumn , Issue 101, 2008, Pages 119-124

  Maas, Andrew I R ^a,b   Lingsma, H F ^b  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

glasgow outcome scale; mortality; prognosis; statistical models; Traumatic brain injury; trial design

Indexed keywords

ARTICLE; CLINICAL TRIAL; COMPUTER SIMULATION; GLASGOW OUTCOME SCALE; HUMAN; MORTALITY; STATISTICAL MODEL; TRAUMATIC BRAIN INJURY; BRAIN INJURY; METHODOLOGY; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; STATISTICS;

BRAIN INJURIES; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; STATISTICS AS TOPIC;

EID: 85052608816     PISSN: 00651419     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-211-78205-7_20     Document Type: Article

References (33)

1. Barer D Ecass ii (1999) Intravenous alteplase in acute ischaemic stroke. European co-operative acute stroke study - ii. Lancet 353:66-67; author reply 67-68
2. Berman MF, Solomon RA, Mayer SA, et al (2003) Impact of hospital-related factors on outcome after treatment of cerebral aneurysms. Stroke 34:2200-2207
3. Butcher I, Maas AI, Lu J, et al (2007) Prognostic value of admission blood pressure in traumatic brain injury: results from the impact study. J Neurotrauma 24:294-302 (Pubitemid 46492151)
4. Butcher I, McHugh GS, Lu J, et al (2007) Prognostic value of cause of injury in traumatic brain injury: results from the impact study. J Neurotrauma 24:281-286 (Pubitemid 46492149)
5. Choi SC (1998) Sample size in clinical trials with dichotomous endpoints: use of covariables. J Biopharm Stat 8:367-375
6. Clifton GL, Miller ER, Choi SC, et al (2001) Lack of effect of induction of hypothermia after acute brain injury. N Engl J Med 344:556-563
7. Cooper DJ, Myles PS, McDermott FT, et al (2004) Prehospital hypertonic saline resuscitation of patients with hypotension and severe traumatic brain injury: a randomized controlled trial. JAMA 291:1350-1357
8. Diringer MN, Edwards DF (2001) Admission to a neurologic/neurosurgical intensive care unit is associated with reduced mortality rate after intracerebral hemorrhage. Crit Care Med 29:635-640
9. Edwards P, Arango M, Balica L, et al (2005) Final results of mrc crash, a randomised placebo-controlled trial of intravenous corticosteroid in adults with head injury-outcomes at 6 months. Lancet 365:1957-1959
10. Hernandez AV, Steyerberg EW, Butcher I, et al (2006) Adjustment for strong predictors of outcome in traumatic brain injury trials: 25% reduction in sample size requirements in the impact study. J Neurotrauma 23:1295-1303
11. Hernandez AV, Steyerberg EW, Habbema JD (2004) Covariate adjustment in randomized controlled trials with dichotomous outcomes increases statistical power and reduces sample size requirements. J Clin Epidemiol 57:454-460
12. Hukkelhoven CW, Steyerberg EW, Habbema JD, et al (2005) Predicting outcome after traumatic brain injury: development and validation of a prognostic score based on admission characteristics. J Neurotrauma 22:1025-1039
13. Hukkelhoven CW, Steyerberg EW, Farace E, et al (2002) Regional differences in patient characteristics, case management, and outcomes in traumatic brain injury: experience from the tirilazad trials. J Neurosurg 97:549-557
14. Maas Al, Steyerberg EW, Murray GD, et al (1999) Why have recent trials of neuroprotective agents in head injury failed to show convincing efficacy? A pragmatic analysis and theoretical considerations. Neurosurgery 44:1286-1298
15. Maas AI, Steyerberg EW, Butcher I, et al (2007) Prognostic value of computerized tomography scan characteristics in traumatic brain injury: results from the impact study. J Neurotrauma 24:303-314 (Pubitemid 46492152)
16. Maas AI, Murray G, Henney W, et al (2006) Efficacy and safety of dexanabinol in severe traumatic brain injury: results of a phase iii randomised, placebo-controlled, clinical trial. Lancet Neurol 5:38-45
17. Machado SG, Murray GD, Teasdale GM (1999) Evaluation of designs for clinical trials of neuroprotective agents in head injury. European brain injury consortium. J Neurotrauma 16:1131-1138
18. Marmarou A, Lu J, Butcher I, et al (2007) Impact database of traumatic brain injury: design and description. J Neurotrauma 24:239-250 (Pubitemid 46492145)
19. Marmarou A, Lu J, Butcher I, et al (2007) Prognostic value of the glasgow coma scale and pupil reactivity in traumatic brain injury assessed pre-hospital and on enrollment: an impact analysis. J Neurotrauma 24:270-280
20. McHugh GS, Butcher I, Steyerberg EW, et al (2007) Statistical approaches to the univariate prognostic analysis of the impact database on traumatic brain injury. J Neurotrauma 24:251-258
21. McHugh GS, Engel DC, Butcher I, et al (2007) Prognostic value of secondary insults in traumatic brain injury: results from the impact study. J Neurotrauma 24:287-293 (Pubitemid 46492150)
22. Murray GD, Barer D, Choi S, et al (2005) Design and analysis of phase iii trials with ordered outcome scales: the concept of the sliding dichotomy. J Neurotrauma 22:511-517
23. Murray GD, Butcher I, McHugh GS, et al (2007) Multivariablc prognostic analysis in traumatic brain injury: results from the impact study. J Neurotrauma 24:329-337 (Pubitemid 46492154)
24. Mushkudiani NA, Engel DC, Steyerberg EW, et al (2007) Prognostic value of demographic characteristics in traumatic brain injury: results from the impact study. J Neurotrauma 24:259-269
25. Narayan RK, Michel ME, Ansell B, et al (2002) Clinical trials in head injury. J Neurotrauma 19:503-557
26. Optimising Analysis of Stroke Trials C, Bath PM, Gray LJ, et al (2007) Can we improve the statistical analysis of stroke trials? Statistical reanalysis of functional outcomes in stroke trials. Stroke 38:1911-1915
27. Roberts I, Yates D, Sandercock P, et al (2004) Effect of intravenous corticosteroids on death within 14 days in 10008 adults with clinically significant head injury (mrc crash trial): Randomised placebo-controlled trial. Lancet 364:1321-1328
28. Von Steinbuechel N, Petersen C, Bullinger M, et al (2005) Assessment of health-related quality of life in persons after traumatic brain injury-development of the qolibri, a specific measure. Acta Neurochir Suppl 93:43-49
29. Steyerberg EW, Bossuyt PM, Lee KL (2000) Clinical trials in acute myocardial infarction: should we adjust for baseline characteristics. Am Heart J 139:745-751
30. Temkin NR, Anderson GD, Winn HR, et al (2007) Magnesium sulfate for neuroprotection after traumatic brain injury: a randomised controlled trial. Lancet Neurol 6:29-38
31. Van Beek JG, Mushkudiani NA, Steyerberg EW, et al (2007) Prognostic value of admission laboratory parameters in traumatic brain injury: results from the impact study. J Neurotrauma 24:315-328
32. Wilson JT, Pettigrew LE, Teasdale GM (1998) Structured interviews for the glasgow outcome scale and the extended glasgow outcome scale: guidelines for their use. J Neurotrauma 15:573-585
33. Wilson JT, Slicker FJ, Legrand V, et al (2007) Observer variation in the assessment of outcome in traumatic brain injury: experience from a multiccnter, international randomized clinical trial. Neurosurgery 61:123-128; discussion 128-129